E09.3542 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy with Combined Traction Retinal Detachment and Rhegmatogenous Retinal Detachment, Left Eye (ICD-10 Code: E09.3542)

Summary

This condition is a form of diabetes mellitus resulting from drug or chemical exposure, characterized by advanced diabetic eye disease. It involves proliferative diabetic retinopathy, where abnormal blood vessel growth in the retina leads to combined traction and rhegmatogenous retinal detachments in the left eye, potentially causing significant vision loss.

Causes

The condition is induced by exposure to drugs or chemicals that disrupt glucose metabolism, leading to uncontrolled hyperglycemia. These substances impair insulin regulation, triggering diabetes that progresses to proliferative diabetic retinopathy. The retinal detachments occur due to abnormal vascular growth and structural changes in the retina.

Risk Factors

• Use of medications or exposure to chemicals known to affect glucose metabolism.
• Pre-existing diabetes or family history of diabetes.
• Long-standing diabetes or poorly controlled blood sugar levels.
• Other risk factors for diabetic retinopathy, such as hypertension or kidney disease.

Symptoms

• Blurred vision or sudden vision loss in the left eye.
• Floaters or dark spots in the visual field of the left eye.
• Distorted or wavy vision.
• Pain or redness in the left eye (less common).

Diagnosis

Diagnosis involves confirming drug or chemical-induced diabetes through clinical history and blood glucose testing. A comprehensive eye examination, including retinal imaging (e.g., optical coherence tomography or fluorescein angiography), is used to assess proliferative diabetic retinopathy and retinal detachments in the left eye.

Treatment Options

Treatment focuses on managing the underlying diabetes and addressing retinal complications. This may include glycemic control, laser photocoagulation, intravitreal injections, or surgical intervention (e.g., vitrectomy) to repair retinal detachments. The left eye is specifically targeted in treatment planning.

Prognosis and Follow-Up

Prognosis depends on the severity of retinal damage and timely intervention. Regular follow-up with an ophthalmologist is essential to monitor retinal changes and adjust treatment. Vision outcomes may vary, with early intervention improving prognosis.

Complications

• Permanent vision loss in the left eye.
• Recurrent retinal detachments.
• Progression to other diabetic eye complications (e.g., macular edema).
• Systemic complications from uncontrolled diabetes.

Lifestyle & Prevention

• Avoid exposure to known diabetogenic drugs or chemicals.
• Maintain strict glycemic control through diet, exercise, and medication.
• Regular eye examinations to detect early retinal changes.
• Manage comorbidities like hypertension or kidney disease.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, floaters, or eye pain in the left eye. Prompt evaluation is critical to prevent permanent damage.

Tips for Medical Coders

Document the specific eye (left eye) and the combined nature of the retinal detachments (traction and rhegmatogenous) to support accurate coding. Ensure clinical documentation confirms drug or chemical-induced diabetes and the presence of proliferative diabetic retinopathy.